责任编辑：小浪快报 资料显示，中金辐照股份有限公司位于广东省深圳市罗湖区东晓街道绿景社区布吉路1028号中设广场B 栋19层，成立日期2003年8月29日，上市日期2021年4月9日，公司主营业务涉及辐照技术服务,为客户提 供医疗保健产品、食品(包括宠物食品)、药品、包装材料等产品的辐照灭菌服务,高分子材料的辐照改性 服务。主营业务收入构成为：辐照技术服务收入94.06%，高温灭菌技术服务收入4.91%，其他(补 充)1.03%。 截至2月10日，中金辐照股东户数1.54万，较上期减少0.70%；人均流通股17118股，较上期增加0.70%。 2025年1月-9月，中金辐照实现营业收入2.78亿元，同比增长2.33%；归母净利润8980.55万元，同比减少 6.35%。 分红方面，中金辐照A股上市后累计派现3.03亿元。近三年，累计派现1.94亿元。 声明：市场有风险，投资需谨慎。本文基于第三方数据库自动发布，不代表新浪财经观点，任何在本文 出现的信息均只作为参考，不构成个人投资建议。如有出入请以实际公告为准。如有疑问，请联系 biz@staff.sina.com.cn。 2月24日，中金辐照涨1.97%，成 ...

Group 1 - The core viewpoint of the news is that Zhongjin Irradiation has shown fluctuations in its financing activities and stock performance, with a notable decrease in net financing and a slight increase in shareholder numbers [1][2]. - As of November 21, Zhongjin Irradiation's stock price increased by 1.20%, with a trading volume of 358 million yuan. The net financing amount was negative at 910.28 million yuan, indicating more repayments than new borrowings [1]. - The company's financing balance is 168 million yuan, which constitutes 3.43% of its market capitalization, indicating a relatively low level compared to the past year [1]. Group 2 - As of November 10, the number of shareholders for Zhongjin Irradiation reached 15,500, reflecting a 0.78% increase, while the average circulating shares per person decreased by 0.77% to 17,021 shares [2]. - For the period from January to September 2025, Zhongjin Irradiation reported a revenue of 278 million yuan, representing a year-on-year growth of 2.33%. However, the net profit attributable to shareholders decreased by 6.35% to 89.81 million yuan [2]. - The company has distributed a total of 303 million yuan in dividends since its A-share listing, with 234 million yuan distributed over the past three years [3].

Core Viewpoint - The stock of Zhongjin Irradiation has shown a positive trend with a year-to-date increase of 5.95%, reflecting investor confidence in the company's growth potential in the irradiation technology service sector [2]. Financial Performance - As of October 20, Zhongjin Irradiation reported a revenue of 180 million yuan for the first half of 2025, marking a year-on-year growth of 0.58%. The net profit attributable to the parent company was approximately 65.81 million yuan, representing a 1.75% increase year-on-year [2]. - The company has distributed a total of 303 million yuan in dividends since its A-share listing, with 234 million yuan distributed over the past three years [3]. Stock Market Activity - On October 23, the stock price increased by 2.03%, reaching 17.57 yuan per share, with a trading volume of approximately 37.44 million yuan and a turnover rate of 0.81%. The total market capitalization stood at 4.639 billion yuan [1]. - The net inflow of main funds was 2.5856 million yuan, with significant buying activity from large orders, indicating strong investor interest [1]. Business Overview - Zhongjin Irradiation, established on August 29, 2003, and listed on April 9, 2021, is located in Shenzhen, Guangdong Province. The company specializes in irradiation technology services, providing sterilization services for healthcare products, food (including pet food), pharmaceuticals, and packaging materials. The revenue composition includes 94.06% from irradiation technology services and 4.91% from high-temperature sterilization services [2]. - The company operates within the social services sector, specifically in professional services, and is associated with concepts such as pre-prepared meals, food safety, and central enterprise reform [2]. Shareholder Information - As of October 20, the number of shareholders for Zhongjin Irradiation was approximately 15,400, a decrease of 0.29% from the previous period. The average number of circulating shares per shareholder increased by 0.29% to 17,176 shares [2].

Group 1 - The core viewpoint of the news highlights the financial performance and market activity of Zhongjin Irradiation, indicating a stable growth in revenue and profit, alongside significant trading activity in its stock [1][2]. Group 2 - As of August 26, Zhongjin Irradiation's stock price decreased by 0.22%, with a trading volume of 156 million yuan. The financing buy-in amount was 41.96 million yuan, while the net financing buy-in was 16.54 million yuan, indicating strong investor interest [1]. - The total financing and securities balance for Zhongjin Irradiation reached 195 million yuan, accounting for 3.98% of its market capitalization, which is above the 80th percentile of the past year [1]. - The company has not engaged in any short selling activities on August 26, with no shares sold or repaid, indicating a lack of bearish sentiment [1]. Group 3 - As of August 8, the number of shareholders for Zhongjin Irradiation increased to 19,600, reflecting an 8.83% rise, while the average circulating shares per person decreased by 8.11% to 13,442 shares [2]. - For the first half of 2025, Zhongjin Irradiation reported a revenue of 180 million yuan, representing a year-on-year growth of 0.58%, and a net profit attributable to shareholders of 65.81 million yuan, up 1.75% year-on-year [2]. Group 4 - Since its A-share listing, Zhongjin Irradiation has distributed a total of 303 million yuan in dividends, with 234 million yuan paid out over the last three years [3].